
Join to View Full Profile
- 2050 Kenny RdFl 4Columbus, OH 43221 
- Phone+1 614-293-5066 
- Fax+1 614-293-9449 
Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Richard Wu is an oncologist in Columbus, OH and is affiliated with Ohio State University Wexner Medical Center. He received his medical degree from McGovern Medical School at UTHealth and has been in practice 6 years. He specializes in melanoma and is experienced in immunotherapy, clinical research, and medical oncology.
Education & Training
 University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2013 - 2016 University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2013 - 2016
 McGovern Medical School at UTHealthClass of 2013, MD McGovern Medical School at UTHealthClass of 2013, MD
 UPMC Medical EducationFellowship, Hematology and Medical Oncology UPMC Medical EducationFellowship, Hematology and Medical Oncology
Certifications & Licensure
 OH State Medical License 2020 - 2026 OH State Medical License 2020 - 2026
 PA State Medical License 2016 - 2021 PA State Medical License 2016 - 2021
 TX State Medical License 2015 - 2017 TX State Medical License 2015 - 2017
 American Board of Internal Medicine Internal Medicine American Board of Internal Medicine Internal Medicine
 American Board of Internal Medicine Medical Oncology American Board of Internal Medicine Medical Oncology
- ABIMHematology
- ABIMMedical Oncology
Publications & Presentations
PubMed
- 1 citationsBRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapy.Himanshu Savardekar, Andrew Stiff, Alvin Liu, Robert Wesolowski, Emily Schwarz
 The Journal of Clinical Investigation. 2025-10-01
- Management of Cutaneous Melanoma, With a Special Focus on Desmoplastic Melanoma.Kari L Kendra, Carlo M Contreras, Claire F Verschraegen, Richard C Wu, Merve Hasanov
 American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2025-06-01
- 1 citationsThe Association of the Microbiome with Melanoma Tumor Response to Immune Checkpoint Inhibitor Treatment and Immune-Related Adverse Events (NCT05102773).Caroline Dravillas, Nyelia Williams, Marium Husain, Rebecca Hoyd, Ahmed Hussein
 Medrxiv. 2025-01-31
Books/Book Chapters
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









